徐州威格顿生物科技有限公司
威格顿生物
Weigedun Biotechnology
PPP1R27 Mouse mAb
规格信息
| 规格 | 货号 |
|---|---|
| 50ul | WGD-Z-2611765 |
| 100ul | WGD-Z-2611765 |
详细参数
| 别名 | Protein phosphatase 1 regulatory subunit 27; Dysferlin-interacting protein 1; Toonin |
| 基因名 | PPP1R27 |
| UniProt ID | Q86WC6 |
| 反应种属 | Human |
| 应用 | IHC-P |
| 宿主 | Mouse |
| 偶联物 | Unconjugated |
| 修饰 | Unmodified |
| 亚型 | IgG1 |
| 克隆号 | 4K6-H5-W7 |
| 克隆性 | Monoclonal Antibody |
| 分子量 | Calculated MW: 17 kDa |
| 纯化方式 | Affinity Purified |
| 产品形式 | Liquid |
| 推荐稀释比 | IHC-1:200-1:250 |
| 存储缓冲液 | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.09% sodium azide |
| 保存温度 | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| 背景信息 | Protein phosphatase 1 regulatory subunit 27 (PPP1R27), also known as Toonin, is a regulatory protein that inhibits the activity of protein phosphatase 1 (PP1) complexes. It functions by binding directly to the phosphatase and modulating its catalytic action on various substrates. One of its key interacting partners is dysferlin, suggesting a role in membrane-related signaling or repair. PPP1R27 is expressed across a wide range of tissues. Clinically, it is associated with skeletal disorders, specifically multiple epiphyseal dysplasia (MED). Mutations or dysregulation of this subunit contribute to developmental abnormalities of epiphyseal growth, leading to joint pain, stiffness, and the early onset of osteoarthritis due to malformation of bone and cartilage. |